Mechanisms of leukemogenesis induced by bovine leukemia virus: prospects for novel anti-retroviral therapies in human

N. Gillet, A.-F. Florins, Mathieu Boxus, Catherine Burteau, Annamaria Nigro, Fabian VANDERMEERS, H. Balon, Amel-Baya Bouzar, Julien Defoiche, Arsène Burny, M. Reichert, R Kettmann, L. Willems

Résultats de recherche: Contribution à un journal/une revueArticleRevue par des pairs

Résumé

[en] In 1871, the observation of yellowish nodules in the enlarged spleen of a cow was considered to be the first reported case of bovine leukemia. The etiological agent of this lymphoproliferative disease, bovine leukemia virus (BLV), belongs to the deltaretrovirus genus which also includes the related human T-lymphotropic virus type 1 (HTLV-1). This review summarizes current knowledge of this viral system, which is important as a model for leukemogenesis. Recently, the BLV model has also cast light onto novel prospects for therapies of HTLV induced diseases, for which no satisfactory treatment exists so far.
langue originaleAnglais
Pages (de - à)18
Nombre de pages1
journalRetrovirology
Volume4
Numéro de publication1
Les DOIs
Etat de la publicationPublié - 2007
Modification externeOui

Empreinte digitale

Examiner les sujets de recherche de « Mechanisms of leukemogenesis induced by bovine leukemia virus: prospects for novel anti-retroviral therapies in human ». Ensemble, ils forment une empreinte digitale unique.

Contient cette citation